Jones Trading analyst Debanjana Chatterjee downgraded Kalvista Pharmaceuticals Inc (NASDAQ: KALV) from Buy to Hold with a price target of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades